Poly Medicure Limited — Investor Meet, 09-09-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Poly Medicure acquired PendraCare Group, a European interventional cardiology products firm, for EUR14.2 million. PendraCare reported EUR9.9 million revenue, EUR1.4 million EBITDA, and 74% gross margin in CY24. This strategic move expands Polymed's global cardiology footprint, providing a European manufacturing base and access to regulated markets. Management anticipates EUR3-4 million in incremental EBITDA from synergies over 3-4 years, leveraging Polymed's manufacturing and R&D strengths. The acquisition enables faster launch of Polymed's cardiology products in Europe and PendraCare's products in India. Future revenue target is EUR25 million by 2030, driven by organic growth and new product pipeline. Sentiment is confident about the strategic fit and long-term value creation.